PureTech Health PLC (PRTC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.71
• Market Cap: $423.91M
• P/E Ratio: 10.32
• EPS: $1.70
• 52-Week High: $20.00
• 52-Week Low: $13.30

Market Sentiment

PureTech Health PLC currently has a Bullish sentiment score of 0.40.

About PureTech Health PLC

PureTech Health PLC is a Boston-based clinical-stage biotherapeutics company dedicated to developing innovative therapies for complex diseases, including inflammatory, fibrotic, immune-related conditions, and various cancers affecting lymphatic and gastrointestinal systems. The company boasts a strong pipeline of drug candidates and leverages its unique research platform alongside strategic collaborations to address significant unmet medical needs. With its expertise in neurological and neuro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PureTech Health PLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PRTC pay dividends?

PureTech Health PLC (PRTC) does not currently pay a regular dividend.

What is PRTC's P/E ratio?

PureTech Health PLC has a price-to-earnings (P/E) ratio of 10.32.

What is PRTC's market cap?

PureTech Health PLC (PRTC) has a market capitalization of $423.91M with a current stock price of $16.71.